Evidence map›Paper›PMID 22053307›Full record

ArticleAsia Pacific allergy2011

Rhinitis in children less than 6 years of age: current knowledge and challenges.

Antony Hardjojo, Antony Hadjojo, Lynette Pc Shek, Hugo Ps van Bever, Bee Wah Lee

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Asia Pacific allergy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04957927 (Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04957927 phase4unknown statusnot on this mapstarted 2020, after this paper: background citation

Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

TypeinterventionalSponsorUsama AzharRan2020 to 2021Enrolled60ConditionsAllergic RhinitisArmsEffectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Otitis media with effusion and atopy: is there a causal relationship?The World Allergy Organization journal · 2017
    Review
  7. Pediatric Severe Chronic Upper Airway Disease (P-SCUAD).Current allergy and asthma reports · 2015
    Review
  8. Allergic Rhinitis in Children: A Randomized Clinical Trial Targeted at Symptoms.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2014
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

  • Erratum issued
    Hadjojo, Antony [corrected to Hardjojo, Antony]
5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Antony HardjojoDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Antony Hadjojo
Lynette Pc Shek
Hugo Ps van Bever
Bee Wah Lee
National University of Singapore · SGNational University Health System · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhinitis is a disease of the upper airway characterized by runny and/or blocked nose and/or sneezing. Though not viewed as a life threatening condition, it is also recognized to impose significant burden to the quality of life of sufferers and their caretakers and imposes an economic cost to society. Through a PubMed online search of the literature from 2006 to September 2011, this paper aims to review the published literature on rhinitis in young children below the age of 6 years. It is apparent from epidemiology studies that rhinitis in this age group is a relatively common problem. The condition has a heterogenous etiology with classification into allergic and non-allergic rhinitis. Respiratory viral infections may play a role in the pathogenesis of long standing rhinitis, but definitive studies are still lacking. Treatment guidelines for management are lacking for this age group, and is a significant unmet need. Although the consensus is that co-morbidities including otitis media with effusion, adenoidal hypertrophy and asthma, are important considerations of management of these children. Pharmacotherapy is limited for young children especially for those below the age of 2 years. This review underscores the lack of understanding of rhinitis in early childhood and therefore the need for further research in this area.

Indexed as

PreschoolPrevalenceReviewRhinitisRisk factors

Identifiers

PMID22053307
PMCPMC3206246
OpenAlexW2085378281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.